CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 9,117 enrolled
Drug / intervention
Tiotropium + Olodaterol (5/5 mcg) +3 moredrug
Likely dose
Tiotropium + Olodaterol (5/5 mcg)from record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05169424
NCT05169424N/ACompleted
CompareCT.gov

Comparison of Exacerbation Risk and Health Outcomes in Maintenance Treatment naïve Chronic Obstructive Pulmonary Disease (COPD) Patients Using Stiolto Versus Trelegy, a Real-World Study

Boehringer Ingelheim·observational·Posted Dec 27, 2021·Updated Oct 19, 2023

In Brief

An observational study evaluating Trelegy Ellipta, Stiolto Respimat, and 2 other interventions for Pulmonary Disease, Chronic Obstructive. Completed, enrolled 9,117 participants across 1 site.

Detailed Summary

This study looks at data from people with chronic obstructive pulmonary disease (COPD). Some used Stiolto Respimat and the others Trelegy Ellipta as their first treatment for COPD. The purpose of this study is to find out how well the treatments worked. Researchers compare the time to first COPD flare-up (exacerbation) between the 2 treatments. The study analyses anonymous data from pharmacy claims collected over 3.5 years.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsPulmonary Disease, Chronic Obstructive
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20222023202420252026
First PostedDec 27, 2021
Enrollment StartDec 17, 2021
Primary CompletionDec 27, 2021
TodayJul 2, 2026
Enrollment to primary: 10 daysPosted 4.5 years ago

Interventions

Trelegy Elliptadevice

Trelegy Ellipta

Stiolto Respimatdevice

Stiolto Respimat

Tiotropium + Olodaterol (5/5 mcg)drug

Tiotropium + Olodaterol (5/5 mcg)

Fluticasone Furoate + Umeclidinium + Vilanterol (100/62.5/25 mcg)drug

Fluticasone Furoate + Umeclidinium + Vilanterol (100/62.5/25 mcg)